← Open Payments lookup

TAMMY TAYLOR-BUFFORD: Open Payments

NPI 1972538718 · CLARKSDALE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$480 in 20 payments from 7 companies in 2025. Trend: 2023 $1,793 · 2024 $722 · 2025 $480

Food & beverage: $480
CompanyPaymentsAmount
Novo Nordisk Inc4$138
AstraZeneca Pharmaceuticals LP6$107
Amgen Inc.2$90
Lilly USA, LLC4$71
Sumitomo Pharma America, Inc.2$34
ABBVIE INC.1$24
Aimmune Therapeutics, Inc.1$16

Products named: Ozempic, FARXIGA, REPATHA, JARDIANCE, GEMTESA, CREON, AIRSUPRA, ZENPEP.

Industry payments across MS — which companies pay providers there.